The
cyclopentenone prostaglandin A2 (
PGA2) is known to inhibit cell proliferation, and metabolism of this compound thus might be important in controlling its ultimate function. The
glutathione-related metabolism of
PGA2 was therefore investigated both with purified
glutathione S-transferase P1-1 (GSTP1-1) and with IGR-39 human
melanoma cells. Firstly, the irreversible inhibition of human GSTP1-1 and its mutants C47S, C101S, and C47S/C101S was studied.
PGA2 appeared to inhibit GSTP1-1 mainly by binding to the
cysteine 47 moiety of the
enzyme. This binding was reversed by a molar excess of GSH, indicating that retro-Michael cleavage occurs. Secondly, after exposing IGR-39 human
melanoma cells to
PGA2, both diastereoisomers of the PGA2-glutathione conjugate are excreted into the medium, although with a clear excess of the S-form, due to its preferential formation by the GSTP1-1 present in the cells. Thirdly, the effect of
PGA2 on intracellular GST activity was determined by quantification of the excreted
glutathione conjugate
S-(2,4-dinitrophenyl)glutathione (DNPSG) after exposure to
1-chloro-2,4-dinitrobenzene. DNPSG excretion was inhibited after incubation with 10 or 20 microM
PGA2 for 1 or 4 hr, as a result of
glutathione depletion, reversible GST inhibition, and covalent modification of intracellular GST. Furthermore,
PGA2 also inhibited transport of DNPSG by the
multidrug resistance-associated protein, an effect that was reversible and competitive. In conclusion,
PGA2 modulates all three aspects of the
glutathione-mediated biotransformation system, i.e. GSH levels, GSTP1-1 activity, and transport of GSH conjugates. A role for GSTP1-1 as a specific
transport protein inside the cell is indicated.